Quick Answer
Bausch Health Companies Inc. reported Total Revenue of $10.27 billion for fiscal year 2025.
Bausch Health Companies Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $10.27B +6.7% |
$9.62B +9.9% |
$8.76B +7.8% |
$8.12B -3.7% |
$8.43B +5.1% |
$8.03B -6.7% |
| Revenue (ASC 606) | $10.27B +6.7% |
$9.62B +9.9% |
$8.76B +7.8% |
$8.12B -3.7% |
$8.43B +5.1% |
$8.03B -6.7% |
| Net Income | $157.00M +441.3% |
-$46.00M +92.2% |
-$592.00M -163.1% |
-$225.00M +76.3% |
-$948.00M -69.3% |
-$560.00M +68.7% |
| Diluted EPS | $0.42 +423.1% |
-$0.13 +92.0% |
-$1.62 -161.3% |
-$0.62 +76.5% |
-$2.64 -67.1% |
-$1.58 +68.9% |
| Total Assets | $26.37B -0.6% |
$26.52B -3.0% |
$27.35B +6.5% |
$25.69B -12.0% |
$29.20B -6.4% |
$31.20B -7.9% |
| Cash and Equivalents | $1.31B +10.8% |
$1.18B +24.7% |
$947.00M +67.9% |
$564.00M -3.1% |
$582.00M -3.8% |
$605.00M -81.3% |
| Long-Term Debt | $20.59B +8.7% |
$18.94B -13.7% |
$21.94B +7.9% |
$20.33B -10.2% |
$22.65B -5.3% |
$23.93B -3.0% |
| Stockholders Equity | -$554.00M +56.7% |
-$1.28B -25.1% |
-$1.02B -47.7% |
-$692.00M -552.8% |
-$106.00M -119.8% |
$535.00M -49.7% |
| Operating Income | $1.81B +17.3% |
$1.55B +60.5% |
$963.00M +112.1% |
$454.00M +0.9% |
$450.00M -33.4% |
$676.00M +433.0% |
| Shares Outstanding | 370.53M +0.7% |
367.84M +0.7% |
365.24M +0.9% |
361.90M +0.7% |
359.41M +1.1% |
355.42M +0.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $2.68B | +6.8% | +6.0% |
| Revenue (ASC 606) | September 30, 2025 | $2.68B | +6.8% | +6.0% |
| Net Income | September 30, 2025 | $179.00M | +310.6% | +20.9% |
| Diluted EPS | September 30, 2025 | $0.48 | +308.7% | +20.0% |
| Total Assets | September 30, 2025 | $26.82B | +1.1% | -1.6% |
| Cash and Equivalents | September 30, 2025 | $1.31B | +81.9% | -24.3% |
| Long-Term Debt | September 30, 2025 | $20.46B | -2.8% | -1.9% |
| Stockholders Equity | September 30, 2025 | -$565.00M | +51.9% | +26.0% |
| Operating Income | September 30, 2025 | $619.00M | +94.7% | +39.4% |
| Shares Outstanding | September 30, 2025 | 370.47M | +0.8% | +0.2% |
- Bausch Health Companies Inc. reported Total Revenue of $10.27 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +6.7% in Total Revenue compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Revenue (ASC 606) of $10.27 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +6.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Net Income of $157.00 million for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +441.3% in Net Income compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Diluted EPS of $0.42 per share for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +423.1% in Diluted EPS compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Total Assets of $26.37 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed a decrease of -0.6% in Total Assets compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Cash and Equivalents of $1.31 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +10.8% in Cash and Equivalents compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Long-Term Debt of $20.59 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +8.7% in Long-Term Debt compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Stockholders Equity of -$554.00 million for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +56.7% in Stockholders Equity compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Operating Income of $1.81 billion for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +17.3% in Operating Income compared to the prior fiscal year.
- Bausch Health Companies Inc. reported Shares Outstanding of 370.53 million shares for fiscal year 2025.
- Bausch Health Companies Inc. showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: